Display options
Share it on

J Pers Med. 2021 Jun 03;11(6). doi: 10.3390/jpm11060506.

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD.

Journal of personalized medicine

Yana V Polonskaya, Elena V Kashtanova, Ivan S Murashov, Evgenia V Striukova, Alexey V Kurguzov, Ekaterina M Stakhneva, Viktoria S Shramko, Nikolay A Maslatsov, Aleksandr M Chernyavsky, Yulia I Ragino

Affiliations

  1. Research Institute of Internal and Preventive Medicine-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (IIPM-Branch of IC&G SB RAS), 175/1 B. Bogatkova Str., 630089 Novosibirsk, Russia.
  2. The Federal State Budgetary Institution "National Medical Research Center Named Academician E.N. Meshalkin" of the Ministry of Health of the Russian Federation, Rechkunovskaya Str., 15, 630055 Novosibirsk, Russia.

PMID: 34205079 PMCID: PMC8228219 DOI: 10.3390/jpm11060506

Abstract

This work is aimed at studying the relationship of matrix metalloproteinases with calcification of the coronary arteries. The study included 78 people with coronary heart disease (CHD) and 36 without CHD. Blood and samples of coronary arteries obtained as a result of endarterectomy were examined. Serum levels of metalloproteinases (MMP) MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-10, MMP-12, and MMP-13 were determined by multiplex analysis. In blood vessel samples, MMP-1, MMP-3, MMP-7, and MMP-9 were determined by enzyme immunoassay; MMP-9 expression was evaluated by immunohistochemistry. Patients with CHD had higher serum levels of MMP-1, MMP-7, and MMP-12. Blood levels of MMP-1 and MMP-3 were associated with calcium levels, MMP-9 with osteoprotegerin and osteonectin, MMP-7 and MMP-10 with osteoprotegerin, MMP-12 with osteocalcin, and MMP-13 with osteopontin. Calcified plaques had higher levels of MMP-1 and MMP-9 compared to plaques without calcification. The relative risk of coronary arteries calcification was associated with MMP-9, which is confirmed by the results of immunohistochemistry. The results obtained indicate the participation of some MMPs, and especially MMP-9, in the calcification processes. The study can serve as a basis for the further study of the possibility of using MMP-1, MMP-7 and MMP-12 as potential biomarkers of CHD.

Keywords: atherosclerosis; calcification; coronary heart disease; metalloproteinases; multiplex assay

References

  1. Biochem Biophys Res Commun. 2016 Feb 5;470(2):287-293 - PubMed
  2. Angiology. 2005 Mar-Apr;56(2):173-89 - PubMed
  3. BMC Cardiovasc Disord. 2016 Sep 30;16(1):185 - PubMed
  4. J Cell Mol Med. 2021 Feb;25(3):1518-1530 - PubMed
  5. PLoS One. 2014 Jan 06;9(1):e84935 - PubMed
  6. Clin Chem Lab Med. 2004 Feb;42(2):121-31 - PubMed
  7. FASEB J. 2004 Apr;18(6):734-6 - PubMed
  8. J Am Coll Cardiol. 2017 Jul 4;70(1):1-25 - PubMed
  9. Am J Pathol. 2006 Feb;168(2):490-8 - PubMed
  10. Mol Biol Rep. 2018 Dec;45(6):2135-2143 - PubMed
  11. Genet Test Mol Biomarkers. 2013 Sep;17(9):707-12 - PubMed
  12. Expert Rev Cardiovasc Ther. 2007 Mar;5(2):265-82 - PubMed
  13. Nephrol Dial Transplant. 2016 May;31(5):789-97 - PubMed
  14. Gene. 2017 Sep 10;628:295-300 - PubMed
  15. Circulation. 2002 Dec 10;106(24):3024-30 - PubMed
  16. Vasc Health Risk Manag. 2015 Feb 27;11:173-83 - PubMed
  17. Circulation. 2006 Apr 25;113(16):1993-2001 - PubMed
  18. Sci Rep. 2019 Dec 16;9(1):19202 - PubMed
  19. Atherosclerosis. 2015 Mar;239(1):268-75 - PubMed
  20. Cardiovasc Diabetol. 2009 Sep 14;8:50 - PubMed
  21. J Cell Mol Med. 2020 Apr;24(7):4261-4274 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2010 May;30(5):1034-42 - PubMed
  23. Gene. 2016 Dec 20;595(1):115-120 - PubMed
  24. Eur Rev Med Pharmacol Sci. 2015;19(14):2583-9 - PubMed
  25. Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1723-31 - PubMed
  26. Atherosclerosis. 2013 Mar;227(1):43-50 - PubMed

Publication Types

Grant support